EHRA provides a series of recommendations for those who seek to offer professional, comprehensive care for women who use drugs and experience gender-based violence (GBV).
McDonald et al. suggest that age-focused explanations are insufficient to account for skyrocketing drug-related deaths, and call for an expansion of harm reduction provision.
C-EHRN provides advice to reduce the harms associated with the unintentional consumption of synthetic cannabinoids in contexts where drug checking services are not available.
HRI examines harm reduction funding allocations in low- and middle-income countries, pointing to a widening gap in necessary funds to meet basic harm reduction needs.
